Cagrilintide

Cagrilintide – Amylin Analogue for Appetite and Energy Regulation Research

Overview:
Cagrilintide (Cagri) is a long-acting amylin receptor agonist studied for its role in appetite regulation, body weight modulation, and metabolic energy balance. As a next-generation peptide analogue of endogenous amylin, it has become a focus of metabolic and neuroendocrine research exploring energy homeostasis, satiety signaling, and fat oxidation pathways.

Scientific Background:
Cagrilintide acts on amylin and calcitonin receptors to regulate food intake and gastric emptying, complementing incretin-based mechanisms such as those influenced by GLP-1. In preclinical research models, it has demonstrated effects on appetite suppression, delayed gastric motility, and enhanced metabolic signaling, making it a valuable tool in the study of obesity, insulin sensitivity, and energy expenditure.

Why Researchers Study Cagrilintide:
Cagrilintide provides researchers with an advanced model for studying energy balance and appetite suppression mechanisms through the amylin receptor system. Its synergistic potential with incretin-based pathways makes it a critical component in exploring the molecular framework of metabolic regulation.

For Laboratory Research Use Only. Not for Human Consumption.